The Patent Finder

Innate Immunotherapeutics Limited

Also on record
Records under this name other than patents Innate Immunotherapeutics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Innate Immunotherapeutics Limited

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,232,010Compositions and methods for treatment of radiation exposure
Lapsed on the fee record
Ended Mar 19, 2023 · USPTO record
Lapsed on the fee recordEnded Mar 19, 2023USPTO record
US 8,709,448Anti-infective agents and uses thereof
Lapsed on the fee record
Ended Apr 29, 2022 · USPTO record
Lapsed on the fee recordEnded Apr 29, 2022USPTO record
US 9,950,025Compositions and methods for treatment of neoplastic disease
Lapsed on the fee record
Ended Apr 24, 2022 · USPTO record
Lapsed on the fee recordEnded Apr 24, 2022USPTO record
US 8,389,479Compositions and methods for treatment of multiple sclerosis
Lapsed on the fee record
Ended Mar 5, 2021 · USPTO record
Lapsed on the fee recordEnded Mar 5, 2021USPTO record
US 9,415,061Compositions and methods for treatment of neoplastic disease
Lapsed on the fee record
Ended Aug 16, 2020 · USPTO record
Lapsed on the fee recordEnded Aug 16, 2020USPTO record
US 8,110,203Adjuvant comprising non-toxic cross-linked muramyl dipeptide (MDP) microparticles derived from Propionibacterium acnes
Lapsed on the fee record
Ended Feb 7, 2020 · USPTO record
Lapsed on the fee recordEnded Feb 7, 2020USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited